| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7282109 | Brain, Behavior, and Immunity | 2013 | 6 Pages |
Abstract
Melatonin secretion is negatively correlated with alterations in serum 25-OH-D in IFN-β treated patients with MS. The finding suggests that melatonin should be considered as a potential mediator of vitamin D neuro-immunomodulatory effects in patients with MS.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Daniel Golan, Elsebeth Staun-Ram, Lea Glass-Marmor, Idit Lavi, Orit Rozenberg, Sara Dishon, Mira Barak, Sophia Ish-Shalom, Ariel Miller,